Yamaguchi Masayoshi, Weitzmann M Neale
Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322-0001, USA.
Int J Mol Med. 2009 Feb;23(2):297-301.
Estrogen (17beta-estradiol) and genistein, a phytoestrogen, are both endowed with anabolic activities on bone in vivo and stimulate osteoblastic differentiation and mineralization in vitro. However, the mechanisms by which these agents promote osteoblastic differentiation and bone anabolic responses are multifactorial and only partly understood. Recently, the NF-kappaB signal transduction pathway was implicated as a negative regulator of osteoblastic differentiation and suppression of this pathway leads to osteoblastic differentiation and mineralization in vitro. To examine whether estrogen and/or genistein regulate osteoblast differentiation by modulating the NF-kappaB pathway, we examined the effect of 17beta-estradiol and genistein on basal and TNFalpha-stimulated NF-kappaB activity in the preosteoblastic cell line MC3T3. MC3T3 cells were transiently transfected with an NF-kappaB responsive luciferase reporter and cultured for 24 h with either vehicle, or physiological doses of 17beta-estradiol (10(-9) to 10(-7) M), or genistein (10(-6) to 10(-5) M). Our data reveal that while 17beta-estradiol had no effect on basal NF-kappaB activity in MC3T3 cells, it significantly antagonized NF-kappaB activity induced by TNFalpha (1 or 10 ng/ml). By contrast, genistein (10(-6) or 10(-5) M) significantly increased NF-kappaB activity, and showed no antagonistic effects on TNFalpha-induced NF-kappaB promoter activity. These studies suggest that the estrogenic compounds, 17beta-estradiol and genistein, mediate very different actions on osteoblastic cells. While 17beta-estradiol may stimulate bone anabolism, in part, by antagonizing TNFalpha-induced NF-kappaB activation, genistein not only fails to prevent cytokine-induced NF-kappaB activation, but directly promotes NF-kappaB activation in MC3T3 cells. These data suggest important mechanistic differences in the mechanisms by which 17beta-estradiol and genistein promote osteoblast differentiation.
雌激素(17β-雌二醇)和染料木黄酮(一种植物雌激素)在体内均对骨骼具有合成代谢活性,并且在体外能刺激成骨细胞分化和矿化。然而,这些因子促进成骨细胞分化和骨骼合成代谢反应的机制是多因素的,目前仅部分为人所知。最近,核因子κB(NF-κB)信号转导通路被认为是成骨细胞分化的负调节因子,抑制该通路可导致体外成骨细胞分化和矿化。为了研究雌激素和/或染料木黄酮是否通过调节NF-κB通路来调控成骨细胞分化,我们检测了17β-雌二醇和染料木黄酮对前成骨细胞系MC3T3中基础和肿瘤坏死因子α(TNFα)刺激的NF-κB活性的影响。将NF-κB反应性荧光素酶报告基因瞬时转染至MC3T3细胞,然后分别用溶剂、生理剂量的17β-雌二醇(10^(-9)至10^(-7)M)或染料木黄酮(10^(-6)至10^(-5)M)培养24小时。我们的数据显示,虽然17β-雌二醇对MC3T3细胞的基础NF-κB活性没有影响,但它能显著拮抗TNFα(1或10 ng/ml)诱导的NF-κB活性。相比之下,染料木黄酮(10^(-6)或10^(-5)M)显著增加NF-κB活性,并且对TNFα诱导的NF-κB启动子活性没有拮抗作用。这些研究表明,雌激素类化合物17β-雌二醇和染料木黄酮对成骨细胞具有非常不同的作用。虽然17β-雌二醇可能部分通过拮抗TNFα诱导的NF-κB激活来刺激骨骼合成代谢,但染料木黄酮不仅不能阻止细胞因子诱导的NF-κB激活,反而直接促进MC3T3细胞中的NF-κB激活。这些数据表明17β-雌二醇和染料木黄酮促进成骨细胞分化的机制存在重要的机制差异。